tag:blogger.com,1999:blog-36762711.post3963802557007912316..comments2023-11-03T06:14:58.449-04:00Comments on Drug and Device Law: The Supreme Court's Preemption TrilogyRachel B. Weilhttp://www.blogger.com/profile/02251124525069607080noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-36762711.post-35341745259561517212008-01-22T11:15:00.000-05:002008-01-22T11:15:00.000-05:00Careful what you wish for, you may be dusting off ...Careful what you wish for, you may be dusting off your resumes when pharma litigation drops off the face of the earth.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36762711.post-30105356763993452882007-12-15T10:41:00.000-05:002007-12-15T10:41:00.000-05:00This post needs a warning label for drug executive...This post needs a warning label for drug executives who might read it and get overexcited.<BR/><BR/>Not a chance that the Supreme Court will take a case arguing that, reading between the lines of the Food and Drug Act, Congress has prohibited mislabeling suits against drug manufacturers for seventy years, though somehow no one knew it before. Not even the Roberts Court. For one thing, even if they did rule that way, Congress would reinstate the right to sue in a heartbeat. <BR/><BR/>Calm down.cartographerhttps://www.blogger.com/profile/08649543782167208999noreply@blogger.com